Tumor necrosis factor-alfa receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis by Karosi, Tamás et al.
The Laryngoscope
VC 2012 The American Laryngological,
Rhinological and Otological Society, Inc.
Tumor Necrosis Factor-a Receptor Expression Correlates
With Mucosal Changes and Biofilm Presence in Chronic
Rhinosinusitis With Nasal Polyposis
Tamas Karosi, MD, PhD; Peter Csomor, MSc; Istvan Sziklai, MD, DSc
Objectives/Hypothesis: Biofilms might play a potential role in the pathogenesis and high recurrence rate of chronic
rhinosinusitis with nasal polyposis (CRSwNP). Biofilm persistence has been thought to correlate with epithelial damage,
subepithelial inflammatory cell infiltration, and tumor necrosis factor-a receptor (TNFR) expression in CRSwNP.
Study Design: Case-control experimental study.
Methods: A total of 36 patients with CRSwNP undergoing endoscopic sinus surgery were analyzed. The negative control
group consisted of eight patients undergoing septoplasty for nasal obstruction without CRSwNP. The nasal polyps and inferior
turbinate mucosa samples applied as negative controls were processed by hematoxylin-eosin (HE) and Gram staining and
TNFR-I and TNFR-II–specific immunofluorescent assay.
Results: Biofilm was detected in 29 of 36 patients with CRSwNP and in none of the eight negative controls. Staining by
HE showed strong correlation with the results of Gram staining protocol. In the biofilm-positive cases, TNFR-I and TNFR-II
displayed homogeneous pattern of significantly increased epithelial expression compared to the biofilm-negative nasal polyps.
In cases of biofilm absence, the expression pattern of TNF-a receptors was characterized by increased TNFR-II–specific immu-
noreaction. It was found that biofilm detectability corresponded to the integrity of nasal epithelium and to the dominant
inflammatory cell type of the subepithelial layer.
Conclusions: Persisting biofilms might increase the epithelial sensitivity against TNF-a that result in epithelium destruction.
Coexistence of biofilms and increased TNFR expression might explain the inflammatory mucosal changes, functional disorders,
and therapy resistance featuring CRSwNP.
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INTRODUCTION
Chronic rhinosinusitis (CRS) is a common inflamma-
tory disease characterized by various symptoms (nasal
obstruction, olfactory dysfunction, nasal discharge, and
tension pain) that persist over 12 weeks.1,2 Chronic rhino-
sinusitis with nasal polyposis (CRSwNP) is a separate
diagnostic and therapeutic entity, although the etiopatho-
mechanism is still uncertain.1,2 Several hypotheses have
arisen as the explanation of the pathogenesis of CRS,
which is currently considered as an immunological
disease affected by multiple factors.3,4 These are immuno-
logical disorders, environmental factors, allergic rhinitis,
bronchial asthma, aspirin intolerance, Staphylococcus
superantigens, fungal infections, and the presence of
different biofilms.2–5
Biofilms are the primary structures of bacterial and
fungal survival and proliferation, which are character-
ized by a self-produced three-dimensional extracellular
matrix that consists of polysaccharides, proteins, nucleic
acids, and water.5–7 Bacterial biofilms are characterized
by extremely high resistance against antibiotics and
host immune reactions due to the physical barrier
formed by the polysaccharide matrix that blocks the dif-
fusion of antibiotics, superoxides, immunoglobulins, and
opsonins.5–7 Biofilms might contribute to the epithelial
damage and subsequent hyperplasia of the subepithelial
layer infiltrated by inflammatory cells.8 Furthermore,
persisting biofilms in CRSwNP cases may be responsible
for surgical failures and high recurrence rate of
disease.1,4,5,7 Because biofilms are reported to play a
central role in the pathogenesis of CRSwNP, a rapid,
inexpensive, and reliable method was necessary for
biofilm detection.5,9 In 2010, Hochstim et al. reported a
reliable and robust method for biofilm detection that
was based on conventional hematoxylin-eosin (HE)
staining of fresh surgical specimens obtained from
patients with CRSwNP.10 In 2011, Toth et al. confirmed
these results by the combined application of HE and
Gram staining protocols.11
Several cytokines (interleukin [IL]-1, IL-4, IL-5,
IL-6, IL-8, and tumor necrosis factor-a [TNF-a]) might
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play important roles in the olfactory dysfunction, which
is a common and debilitating symptom of patients with
CRSwNP.12–14 The epithelial damage, desensitization of
odorant-induced signaling, and apoptotic loss of olfactory
neurons are mainly associated with increased TNF-a
production in the subepithelial layer of nasal polyps.12,13
Furthermore, TNF-a inhibits the regeneration of imma-
ture olfactory neurons from their progenitor cells located
in the basal layer of the olfactory epithelium.12,13 How-
ever, the mechanism of olfactory dysfunction in
CRSwNP is not completely understood.12,13 TNF-a can
also have adverse effects on the respiratory mucosa,
causing ciliated cell loss, epithelial metaplasia, and fur-
ther accumulation of inflammatory cells in the
subepithelial layer.8,14 The association between biofilm
presence and proinflammatory cytokine expression, how-
ever, is not clear.15
Biological effects of TNF-a are mediated by two dif-
ferent receptors.16,17 Type I TNF-a receptor (TNFR-I), a
member of TNF superfamily I, is generally expressed by
all nucleated human cells and has a broader spectrum of
biological influences than type II TNF-a receptor (TNFR-
II).18,19 TNFR-II, a member of TNF superfamily II, is
exclusively expressed by lymphocytes and antigen pre-
senting cells.16,18 Increased expression of TNFR-II is
usually seen in acute inflammatory reaction, because it
plays an important role in the recruitment of T-helper
cells via induction of proinflammatory cytokine release
(IL-1, IL-4, IL-5, IL-6, and TGF-b).17,18 Activated TNFR-I
forms a homotrimer structure activating the silencer of
death domains, which binds the TNFR-associated death
domain, allowing three different ways of signal transduc-
tion.20 The first and most important way is the activation
of the nuclear factor kappa-light-chain-enhancer of acti-
vated B cells system providing inflammatory cell survival
and proliferation.20,21 The second way is the activation of
the mitogen-activated protein kinases (MAPK) system,
which is associated with the phosphorylation of several
transcription factors (c-Jun N-terminal kinase, p38-
MAPK, extracellular signal-regulated kinases)AQ1 leading to
intense inflammatory cell proliferation.20,21 The third
way of TNFR-I-associated signalization is the death
domain-mediated and caspase-associated induction of
apoptosis.20,22
This study investigated the presence of biofilms on
the surface of nasal polyps corresponding to the subepi-
thelial inflammatory changes and epithelial TNF-a
receptor expression.
MATERIALS AND METHODS
Patients and Controls
A case-control experimental study was performed on nasal
polyp specimens obtained from patients with CRSwNP who
underwent endoscopic sinus surgery (ESS) in the Department
of Otorhinolaryngology and Head and Neck Surgery, University
of Debrecen. Nasal polyps were collected between February
2010AQ2 and July 2010. The group of 36 patients consisted of 21
men and 15 women (mean age, 46.7 years; range, 27–71 years)
with the diagnosis of CRSwNP confirmed by nasal endoscopy
and computed tomography (CT) scans of paranasal sinuses. The
Lund-Mackay scores of coronal reconstructed CT scans varied
between 9 and 24, with an average score of 20 indicating seri-
ous involvement of paranasal sinuses by CRS. The score was
higher than 20 in 80% of patients (n ¼ 29). The clinical history
and findings of physical examinations were obtained during
confirmation of the diagnosis of CRSwNP. Clinical information
on bronchial asthma, allergic rhinitis, aspirin intolerance, previ-
ous ESS, topical steroid treatment, and systemic antimicrobial
therapy was recorded before surgery. Five patients (13%) had
bronchial asthma, 8% (n ¼ 3) had allergic rhinitis, and 3% (n ¼
1) had the diagnosis of aspirin intolerance. This patient had
complete acetylsalicylic acid triad (aka, Samter’s triad: nasal
polyposis, bronchial asthma, and aspirin intolerance).1,2 Diagno-
sis of allergic rhinitis was based on the clinical history, physical
examination, and allergen-specific intracutaneous skin-prick
test. In some cases, inhalation allergen-specific serum immuno-
globulin G (IgG) levels were also measured by enzyme-linked
immunosorbent assay. The diagnosis of bronchial asthma was
based on the clinical history and on the respiratory functional
test. The diagnosis was stated by a pulmonologist in all cases.
Aspirin intolerance was based on the presence of aspirin-
induced hypersensitive reaction in the clinical history of the
patients. Repeated ESS was performed in 22% (n ¼ 8) of
patients, which is an important predictive factor for CRS recur-
rence. In this group, the number of previous surgeries varied
between one and six, with an average ESS number of 2.3. All
patients were treated by topical mometasone furoate monohy-
drate (Nasonex; Merck/Schering-Plough, North Wales, PA),
200 lg/day before surgery. The average period of intranasal
steroid treatment was 27.3 months, which varied between 5
and 57 months. Preoperative systemic antibiotic treatment was
performed in two (5%) patients due to recurring acute rhinosi-
nusitis. Table T1I summarizes the clinical history of patients with
CRSwNP.
All the nasal polyps collected during ESS were processed
by histopathological analysis. Only nasal polyps larger than 2
cm and could be removed by a straight ESS forceps without any
surface injury or iatrogenic disruption of biofilm layers were an-
alyzed. The removal was gently performed at the roots of the
nasal polyps.
Eight patients (males ¼ 7; females ¼ 1; mean age, 41.3
years; range, 22–57 years) scheduled for septoplasty for nasal
obstruction without a medical history of CRS were recruited
into the negative control group. Tissue specimens of approxi-
mately 0.2 cm3 were obtained from the anterior mucosal surface
of the inferior turbinate. All patients gave their informed
consent before donating their tissue samples for the study. The
TABLE I.
Clinically Relevant Data of Patients With Chronic Rhinosinusitis
With Nasal Polyposis.
Characteristic Value
No. of patients 36
Gender ratio (F/M) 0.71 (15/21)
Average age (range), yr 46.7 (27–71)
Bronchial asthma, no. (%) 5 (13)
Allergic rhinitis, no. (%) 3 (8)
Aspirin intolerance, no. (%) 1 (3)
Average Lund-Mackay score (range) 20 (9–24)
Previous ESS, no. (%) 8 (22)
Topical steroid treatment, no. (%) 36 (100)
Systemic antibiotic treatment, no. (%) 2 (5)
F/M ¼ female/male; ESS ¼ endoscopic sinus surgery.
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institutional ethical committee approved our study. The study
was carried out according to the Declaration of Helsinki.
HE and Gram Staining
A combination of HE and Gram staining protocols is a
reliable method for the detection of biofilm presence and corre-
sponding histopathological changes, because HE staining is for
the investigation of microscopic architecture, whereas the Gram
protocol stains various microbiological elements.11 A total of 44
nasal mucosa specimens were fixed in 10% w/v formaldehyde.
Specimens were embedded in 15% (w/v)AQ3 purified gelatin for
24 hours at 56C and refixed in 4% (w/v) paraformaldehyde for
24 hours at 20C. Blocks were cryoprotected in 20% (w/v) sucroseAQ4
solution for 2 hours at 4C and sectioned into 5-lm slides at
25C (MNT-200; Slee, Mainz, Germany). Slides were stored in
0.1 M phosphate-buffered saline (PBS) containing 0.03% (w/v)
sodium azide at 4C. Three consecutive 5-lm frozen cut sections
were examined as follows: 1) conventional staining with HE, 2)
conventional Gram staining, and 3) TNFR-I– and TNFR-II–spe-
cific immunofluorescent assays (IFA). Histological pretreatment
protocol was performed by an independent laboratory assistant.
Histological examinations were blinded for two independent
researchers; one researcher analyzed the sections stained by HE
and Gram (P.C.), and the other examined the results of IFA (T.K.).
The criteria for the histological detection of biofilms were
based on the presence of characteristic polysaccharide layer with
Gram-positive or Gram-negative microcolonies. The architecture
of epithelium and the subepithelial cellular infiltration were
correlated to the presence or absence of biofilms and to the
expression pattern of type I and II TNF-a receptors.
TNFR-I– and TNFR-II–Specific IFA
The third sections AQ5were washed for 20 minutes at 20C in
0.2 M PBS containing protein block solution (1% [w/v], bovine
serum albumin, 0.09% [w/v], sodium azide, 0.1% [w/v], Tween-
20) (BioGenex, San Ramon, CA). Blocked sections were
incubated with 0.005 mg/mLpolyclonal goat anti-human TNF
RI/TNFRSF1A antibody solution (100 mL, 20C, for 24 hours,
continuous shaking) (R&D Systems, Minneapolis, MN). The
first primary antibody was washed with 0.2 M PBS. Sections
were incubated with 0.02 mg/mL monoclonal mouse hybridoma
anti-human TNF RII/TNFRSF1B antibody solution (100 mL,
20C, for 24 hours, continuous shaking) (R&D Systems). The
second primary antibody was washed with 0.2 M PBS. Sections
were incubated with 0.005 mg/mL Northern Lights donkey
anti-goat IgG labeled by NL-493 fluorochrome (50 mL, 20C, for
12 hours, continuous shaking) (R&D Systems). The first second-
ary antibody was washed with 0.2 M PBS. Sections were
incubated with the second secondary antibody: 0.005 mg/mL
Northern Lights donkey anti-mouse IgG labeled by NL-637
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Fig. 1. Histopathological examination of a chronic rhinosinusitis with nasal polyposis specimen. (A) The respiratory epithelium shows a
squamous cell metaplasia. A bulky and continuous biofilm layer can be identified on the surface of the epithelial layer (black arrow). The
subepithelial layer is predominantly infiltrated by eosinophil granulocytes (empty arrows). (B) Gram staining indicates a bacterial biofilm con-
sisted of Gram-positive cocci (small insert). (C) The epithelial layer represents intense tumor necrosis factor-a receptor (TNFR)-I–specific
immunoreaction (empty arrow). Mononuclear cells and plasmacytes show strong cytoplasmic immunostaining for TNFR-I (white arrow).
(D) Immunofluorescent assay for TNFR-II exhibits the same expression pattern. Empty and white arrows indicate identical structures of the
previous section. H.E. ¼ hematoxylin-eosin.
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fluorochrome (50 mL, 20C, for 12 hours, continuous shaking)
(R&D Systems). All antibody incubations were performed in a
sterile humid chamber. Slides were covered by ultraviolet (UV)
transparent mounting medium (PromoFluor Antifade Reagent;
Promocell, Heidelberg, Germany). Imaging was performed
under UV light with 510 nm wavelengths for NL-493 and 650
nm for NL-637 fluorochrome with 96 to 123 ms exposure time.
Photographs were archived in jpeg file format (Axioskop2 MOT,
Axiovision 4.0; Zeiss, Oberkochen, Germany). Average cell
counts with detectable TNFR-I and II expression were meas-
ured in a 200 mm  200 mm centrally focused area of the
epithelial layer. Statistical analysis was performed by Mann-
Whitney U test with a 95% confidence interval using SPSS ver-
sion 9.0 for Windows (SPSS, Inc. Chicago, IL).
RESULTS
Altogether, 36 patients with CRSwNP who under-
went ESS were included in this study. The
histopathological examination revealed inflammatory
nasal polyps with eosinophilic, polymorphonuclear, and
plasmacyte infiltration of the subepithelial layer in all
cases. Bacterial (n ¼ 21), fungal (n ¼ 4), or combined
(n ¼ 4) biofilms were detected in 29 (80.5%) of 36
patients with CRSwNP (Fig. F11, Table T2II). In the biofilm-
negative cases (n ¼ 7, 19.5%), histopathological analysis
revealed ciliated columnar epithelium with predomi-
nantly eosinophilic infiltration of the subepithelial layer
(Fig. F22, Table II). All patients diagnosed with allergic
TABLE II.
Histopathological Characteristics of Epithelial and Stromal Layers of Nasal Polyps Depending on Biofilm Presence.
Nasal Polyps–CRS Specimens (HE and Gram Staining, N ¼ 36)
Biofilm Positive (n ¼ 29, 80.5%) Biofilm Negative (n ¼ 7, 19.5%)
Epithelium Fragmented columnar epithelium without ciliated cells (n ¼ 17),
squamous cell metaplasia (n ¼ 12)
Ciliated columnar epithelium (n ¼ 7)
Subepithelial layer Eosinophil dominancy (n ¼ 2), neutrophil dominancy (n ¼ 24),
plasmacyte dominancy (n ¼ 3)
Eosinophil dominancy (n ¼ 5),
neutrophil dominancy (n ¼ 0),
plasmacyte dominancy (n ¼ 2)
HE ¼ hematoxylin-eosin.
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Fig. 2. Histopathological analysis of a chronic rhinosinusitis with nasal polyposis specimen. (A) Disorganized columnar epithelium and
empty foamy cells can be detected (black arrow). Basal lamina is a well-identified structure. The subepithelial layer is infiltrated by plasma-
cytes (empty arrow). (B) Biofilm structures cannot be detected on the surface of nasal epithelium. (C) Tumor necrosis factor-a receptor
(TNFR)-I–specific immunostaining is practically negative for epithelial cells (empty arrow). In contrast, subepithelial mononuclear cells show
intense immunoreaction (white arrow). (D) The apical part of the epithelial cells represents a considerable TNFR-II–specific immunoreaction
(empty arrow). Empty and white arrows indicate identical structures of the previous section. H.E. ¼ hematoxylin-eosin.
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rhinitis (n ¼ 3, 42.8%) were recruited into the biofilm
negative group (n ¼ 7) (Table II). In our series, HE
staining displayed a strong correlation with the results
of Gram staining and was found to be a reliable predic-
tor of the presence or absence of biofilms. No
discrepancies were found between the two staining pro-
tocols (Table II). Disintegration or squamous cell
metaplasia of the epithelial layer due to the subepithe-
lial inflammatory reactions were strong predictors for
biofilm detection (Fig. 1, Table II). Among biofilm-posi-
tive cases, neutrophil infiltration of the subepithelial
layer was found to be the most important factor of bio-
film presence (Fig. 1, Table II). In the biofilm-positive
specimens, histopathological characteristics of the respi-
ratory mucosa and the dominant inflammatory cell type
of the subepithelial layer were strongly associated with
the increased TNFR-I and II expression (Fig. 1). There
was no statistically significant difference between the
number of TNFR-I and II expressing cells (Fig.F3 3). It
was found that normal respiratory mucosa with colum-
nar ciliated epithelium is not associated with the
presence of different types of biofilms (Fig. 2, Table II).
Furthermore, predominant eosinophil infiltration of the
subepithelial layer decreased the chance of biofilm detec-
tion (Fig. 2, Table II). According to IFA results, biofilm-
negative cases were characterized by significantly
decreased TNFR-I and II expression compared to bio-
film-positive specimens (P < .001) (Fig. 3). It was shown
that the average number of TNFR-II–positive epithelial
cells was significantly higher than the TNFR-I express-
ing population (P < .05) (Fig. 3). No biofilm-like
structures were detected in mucosal specimens obtained
from the inferior turbinate of patients (n ¼ 8) applied as
negative controls (Fig. F44). In negative controls, the
TNFR-I and II expressing cells were significantly under-
represented in the epithelial layer of the nasal mucosa
(Fig. 4).
DISCUSSION
In the present study, we demonstrated the presence
of biofilms in 29 patients with CRSwNP by the combined
application of HE and Gram protocols. Absence of bio-
films was not associated with the single employment of
HE or Gram staining. Furthermore, biofilm detection
showed statistically significant correlation to the
increased TNFR-I and II expression in the epithelial
layer of nasal polyps. Although the presence of biofilm
itself is supposed to be one of the most important factors
in the pathogenesis of CRSwNP, microbiological identifi-
cation of different bacterial and fungal species involved
in biofilm formation still requires culturing or fluores-
cence in situ hybridization analysis with species-specific
oligonucleotide probes.5,9,10
There is increasing evidence that biofilms affect the
intensity of subepithelial inflammatory reaction in
CRSwNP.4,15 Plasmacytes, neutrophil and eosinophil
granulocytes accumulating in the subepithelial layer of
nasal polyps are responsible for the uncontrolled release
of several proinflammatory cytokines.3,14 Increased
expression of these peptides—mainly TNF-a—has seri-
ous morphological and functional consequences affecting
the integrity of respiratory and olfactory mucosa.3,12,13
In general, cytokines produced by T-helper cells
such as IL-4 and IL-5 are overexpressed in CRSwNP.3,14
It has been reported that single nucleotide polymor-
phism (SNP) of IL-4 promoter region is associated with
nasal polyps, and IL-4 appears to modify the metabolic
activity of fibroblasts AQ6.3,23 Enterotoxin B of Staphylococ-
cus species induces IL-5 release in the subepithelial
layer, whereas IL-8 seems to be upregulated by Staphy-
lococcus epidermidis.3,24,25 Both cytokines are supposed
to increase the subepithelial matrix production in nasal
polyps.3,24 IL-1 and TNF-a being proinflammatory
cytokines are upregulated in CRSwNP, which can be
associated with several disease-specific SNPs previously
identified.26 B-cell activating factor has been also
reported to contribute to the pathogenesis of CRSwNP
via the local induction of immunoglobulin A production
and activation of eosinophil granulocytes.27 In contrast,
cytokines having immunomodulator effects such as
interferon-c and transforming growth factor-b are down-
regulated in nasal polyps.3
In spite of the intense research, the mechanism of
olfactory dysfunction and architectural changes of the
nasal mucosa remains poorly understood in CRSwNP.12,13
TNF-a has been suggested to play a crucial role in olfac-
tory dysfunction by the suppression of progenitor cell
proliferation and olfactory regeneartion.13 In the trans-
genic mouse model for CRS, electro-olfactography AQ7results
implied that TNF-a directly lead to olfactory neuron
dysfunction that was independent from the severity of
inflammatory reactions.13 This inflammatory process
Fig. 3. Average number of tumor necrosis factor-a receptor
(TNFR)-I– and TNFR-II–positive epithelial cells in negative controls
and in nasal polyps correlated to biofilm presence. The error bars
indicate standard error of meanAQ8 . *Cell counts were measured in a
200 mm  200 mm centrally focused area of the epithelial layer.
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seems to be reversible, because TNF-a does not directly
cause neuronal apoptosis.12,13 It has been reported that
intranasal and oral administration of steroids (predniso-
lone, mometasone furoat) significantly decreases the
expression levels of IL-1, Il-6 and TNF-a in nasal pol-
yps.14,24 These findings also support the hypothesis that
the inflammatory reactions in CRSwNP are correlated to
the elevated levels of proinflammatory cytokines.3,14,24
Corticosteroids have beneficial effects on the symp-
toms of CRSwNP and significantly decrease nasal
obstruction and olfactory dysfunction.1,2,14,15 Hypotheti-
cally, steroid treatment may have adverse effects on the
biofilm presence and thickness via the inhibition of local
immune response.11 As we have concluded previously,
steroid and systemic antibiotic treatment might have a
severe influence on the flora of nasal mucosa, and in
fact these medications might affect the structure and
thickness of biofilms.11 Because our patients were all
treated by topical steroids, this association seems to be
strong. In contrast, 43% of biofilm-negative specimens
were obtained from patients with allergic rhinitis who
were regular topical-steroid users. Furthermore, allergic
rhinitis is not a real risk factor for CRSwNP by the cur-
rent rhinologic consensus.1,2 In the future, placebo-
controlled, double-blinded, dynamic studies will be nec-
essary to prove this causative relation and to resolve
this conflict.
CONCLUSION
The results of this study indicate an association
between biofilm presence and increased expression of
TNF-a receptors in CRSwNP. According to our observa-
tions, the severity of CRSwNP is associated with
increased TNF-a receptor expression and consecutive
epithelial damage, which is more likely to become colon-
ized with bacteria. Although specific treatments are not
yet available to target biofilm, its detection is an impor-
tant requirement, because it is strongly associated with
treatment failures and persistent symptoms of
CRSwNP.1,2,10,11,28 In general, therapeutic considerations
can be divided into two main groups: blockade of biofilm
formation and eradication of biofilms that have already
formed.28 Furthermore, an understanding of the role of
TNF-a and its receptors in biofilm-positive CRSwNP
cases may suggest novel therapeutic strategies for CRS-
associated symptoms in the future. Further examina-
tions are required to clarify the etiologic role of biofilms
in the pathogenesis of CRSwNP.
C
O
L
O
R
Fig. 4. Histopathological representation of a normal nasal mucosa specimen obtained from the inferior turbinate. (A) At high magnification,
an intact ciliated columnar epithelium (black arrow) and a well-defined basal lamina (white arrow) can be detected. The subepithelial layer
represents heterogeneous populations of plasmacytes, neutrophils, and eosinophils (empty arrow). (B) Biofilm cannot be detected on the
surface of the epithelial layer (black arrow). (C) The ciliated columnar cells represents weak, almost negative, immunostaining for type I
tumor necrosis factor-a receptors (TNFR-I) (empty arrow). Mononuclear cells and plasmacytes show a considerable positivity for TNFR-I
(white arrow). (D) TNFR-II displays a quite similar expression pattern. Empty and white arrows indicate identical structures of the previous
section. H.E. ¼ hematoxylin-eosin.
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